The TRPA1 gene helps make a sensor on certain nerve cells that detects irritating chemicals such as smoke, wasabi, and tear gas, helping trigger pain, cough, and other protective reflexes. If this gene does not work normally, you may notice stronger or weaker responses to chemical irritants, and a few rare variants are linked to inherited episodes of pain. This gene can play a role in how your body responds to inflammation in the airways, skin, and gut. Many variants in this gene have little effect on health.
What is a gene?
Genes are stretches of DNA that give your cells instructions for making molecules or regulating processes in the body. Some genes provide the directions for producing proteins, which are the working parts of cells. Other genes mainly control when certain processes happen, where they take place, and how strongly they operate. Together, genes affect how the body develops and functions, and they can influence how you respond to food, stress, and medications. For a more detailed look at this topic, you can find additional information in the LearnHub.
Overview
TRPA1Gene function
What if the gene works
The TRPA1 gene helps make a sensor on certain nerve cells that responds to irritating chemicals and other warning signals. This supports pain sensing, coughing, and other protective responses.
Risk
What if the gene does not work
Variants in the TRPA1 gene can cause familial episodic pain syndrome, with pain attacks often triggered by cold, fasting, or exertion. Milder or more severe variants may affect when symptoms start and how strong they feel.
Treatment
What does that mean for your treatment
For people with a pathogenic or loss-of-function variant in the TRPA1 gene, no gene-specific treatment or drug selection approach is currently established in clinical guidelines. The TRPA1 gene is being studied as a drug target for pain, itch, and some airway symptoms, but these treatments are still in research.
Conditions associated with TRPA1
Gene function
What if the gene works
The TRPA1 gene helps certain nerve endings act like chemical alarm sensors. It is most active in pain sensing nerves, where it detects irritating substances and sends fast warning signals to the brain. Understanding what the TRPA1 gene does in the body helps explain why things like smoke or wasabi can trigger a sharp, protective response.
The TRPA1 gene makes a channel protein that opens when irritating chemicals touch certain nerve endings. This lets charged particles move into the cell and starts a warning signal.
When this channel opens, the nerve cell becomes more likely to fire and pass along pain messages. This helps your body notice potentially harmful exposures and react.
TRPA1 also responds to some substances your body makes during irritation or inflammation. That helps sensory nerves detect local stress and support protective reflexes such as pulling away from an irritant.
What is a variant?
A genetic variant is a small difference in the DNA sequence of a gene. These changes are common and help explain normal human diversity, such as differences in appearance, metabolism, or how the body responds to environmental factors. Many variants do not have any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant can change how a gene works to a greater extent and may contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the TRPA1 gene can change how this ion channel folds, reaches the cell surface, or opens in response to triggers, which helps explain how TRPA1 gene variants affect pain signaling. Some variants make the channel easier to activate or keep it open longer, leading to extra nerve signaling. Others reduce channel activity or make the protein less stable. A milder or more severe functional change can influence whether pain episodes linked to familial episodic pain syndrome begin earlier or feel more intense.
How variants are linked to conditions
Some variants in the TRPA1 gene cause familial episodic pain syndrome, a rare inherited condition with repeated pain attacks that may start in infancy or childhood. This is the clearest TRPA1 gene variant and pain condition link in human genetics, and a pathogenic variant can confirm the diagnosis. Other reported links, such as differences in pain sensitivity or airway symptoms, have been studied but are not established enough to diagnose a specific condition on their own.
A variant is not necessarily a diagnosis
Genetic variants are a routine feature of human biology and are widely found across the general population. Most do not directly affect health and instead reflect normal human diversity. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences contribute. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific factors that increase or reduce health risk related to the TRPA1 gene itself. Some changes in TRPA1 may influence sensitivity to irritants, cold, or pain, but overall risk is also shaped by many other genes and everyday exposures.
Inheritance of TRPA1 variants
TRPA1-related familial episodic pain syndrome is inherited in an autosomal dominant pattern. This means a person with a disease-causing variant in the TRPA1 gene has a 50% chance of passing it on to each child, whether the child is a son or a daughter. In practical terms, how variants of the TRPA1 gene are inherited often looks like the condition appearing across several generations in a family. A child who does not inherit the variant will not pass that same familial variant on to their own children.
What does my TRPA1 result mean for my family?
Some TRPA1 changes are linked to a rare inherited pain condition that can run in families in a dominant pattern, so close relatives such as a parent, brother, sister, or child may also carry the same change. For many families, this means relatives with similar episodes of severe pain may want to discuss the family result with their own clinician or a genetic counselor. In some families, the change may be new in one person rather than inherited from a parent.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a change in the TRPA1 gene, a lab can do genetic testing for TRPA1 variants using a saliva sample or a blood test. The lab reads the gene’s DNA code and compares it with the usual sequence, then reports whether a variant was found and what it may mean.
When should I consider getting a genetic test?
Testing for the TRPA1 gene may be worth discussing if there is a personal or family history of repeated attacks of intense upper-body pain that began early in life, especially when episodes are triggered by fasting, cold, or illness. A harmful change in TRPA1 can confirm a rare inherited pain condition and help clarify whether relatives could be affected.
A genetic result is only one part of your health story
A genetic result can provide useful insight, but how much it explains depends on the condition and the kind of variant present. Lifestyle, environment, age, and medical history are among the many factors that shape how the body works over time. In some conditions, especially those influenced by many genes, genetic information offers context rather than certainty and is best understood together with other parts of care. In other situations, a genetic result can give a clear answer. In areas like medication response, genetic results can help put individual experiences into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, moves it through the body, or responds to it at its target. This is one reason the same treatment may work well for one person, help only a little in another, or cause more side effects in someone who is more sensitive to it.
What is Pharmacogenetics?
Pharmacogenetics looks at how genetic variation can shape a person’s response to medicines. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. For many medicines, genes influence both how strongly a drug works and how the body handles it. This information can support more informed, more individualized treatment decisions. You can read more about this topic in the LearnHub.
Drugs influenced by the TRPA1 gene
When should I seek medical advice?
There is not yet a widely accepted role for this gene in choosing or adjusting medicines, so any questions about treatments, side effects, or symptoms are best discussed with your doctor.
History
The TRPA1 gene entered research through work on the larger transient receptor potential channel family in the late 1990s, when scientists were mapping genes involved in how the body senses the environment. Initially understood only through visible traits, later recognized as tied to a specific gene, this area of research moved forward as TRPA1 was identified in sensory nerves. From these first observations, research expanded steadily. In the 2000s, TRPA1 became much better known after studies showed it responds to pungent plant chemicals such as those in mustard oil and wasabi, bringing it into mainstream pain and sensory research. Over time, descriptions became more precise, linking TRPA1 to cold sensing, irritation, and inflammatory pain. These historical steps shaped today’s understanding.